Search Results
Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Search for other papers by Maria Prado Talavera Rubio in
Google Scholar
PubMed
Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
underwent RRA after thyroid hormone withdrawal (THW) or administration of recombinant human thyroid-stimulating hormone (rhTSH). pTg, pAntiTgAb and preablation TSH (pTSH) levels were measured. Patients were required to have TSH levels > 30 mU/L at the time
Search for other papers by Diogo Mendes in
Google Scholar
PubMed
Laboratory of Social Pharmacy and Public Health, School of Pharmacy, University of Coimbra, Coimbra, Portugal
Search for other papers by Carlos Alves in
Google Scholar
PubMed
Search for other papers by Nuno Silverio in
Google Scholar
PubMed
Laboratory of Social Pharmacy and Public Health, School of Pharmacy, University of Coimbra, Coimbra, Portugal
Search for other papers by Francisco Batel Marques in
Google Scholar
PubMed
severe subclinical hypothyroidism [ 2 , 22 - 24 ]. Moreover, the TSH concentration usually normalizes within 2 years for 46% of patients with subclinical hypothyroidism if the TSH level is <7 mIU/L in a single measurement [ 61 - 63 ]. Yet, the risk of
Search for other papers by Ladan Mehran in
Google Scholar
PubMed
Search for other papers by Atieh Amouzegar in
Google Scholar
PubMed
Search for other papers by Hengameh Abdi in
Google Scholar
PubMed
Search for other papers by Negar Delbari in
Google Scholar
PubMed
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Search for other papers by Elham Madreseh in
Google Scholar
PubMed
Search for other papers by Maryam Tohidi in
Google Scholar
PubMed
Search for other papers by Mohammad Ali Mansournia in
Google Scholar
PubMed
Search for other papers by Fereidoun Azizi in
Google Scholar
PubMed
-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt . J Endocrinol Invest . 2008 May ; 31 ( 5 ): 422 – 31 . http
Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed
Search for other papers by Konstantinos Dimitropoulos in
Google Scholar
PubMed
Search for other papers by Irene Mamali in
Google Scholar
PubMed
Search for other papers by Ioulia Tseti in
Google Scholar
PubMed
Search for other papers by George Sakellaropoulos in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed
thereafter. They were also instructed not to take their LT4 preparation before blood sampling on the scheduled visits for thyroid hormone measurements. We set the therapeutic target range of TSH levels at 0.45–4.12 mIU/L [ 8 ], since Greece is an iodine
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
sufficient TH concentrations at the cellular level. Therefore, the necessity of TH replacement therapy remains uncertain now, although concentration, energy level and signs of myxoedema of one patient improved after starting T4 replacement therapy, which
Department of Clinical Sciences and Community Health, University of Milan, Italy
Search for other papers by Ilaria Muller in
Google Scholar
PubMed
Search for other papers by Anita Daturi in
Google Scholar
PubMed
Search for other papers by Matteo Varallo in
Google Scholar
PubMed
Search for other papers by Tiziana E Re in
Google Scholar
PubMed
Search for other papers by Davide Dazzi in
Google Scholar
PubMed
Search for other papers by Sara Maioli in
Google Scholar
PubMed
Search for other papers by Erica Crivicich in
Google Scholar
PubMed
Search for other papers by Francesco Di Marco in
Google Scholar
PubMed
Search for other papers by Virgilio Longari in
Google Scholar
PubMed
Search for other papers by Beatrice Dazzi in
Google Scholar
PubMed
Search for other papers by Massimo Castellani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Italy
Search for other papers by Giovanna Mantovani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Italy
Search for other papers by Maura Arosio in
Google Scholar
PubMed
Search for other papers by Mario Salvi in
Google Scholar
PubMed
function tests in the context of euthyroidism, due to a complex combination of adaptive and maladaptive mechanisms, known as non-thyroidal illness syndrome (NTIS) and characterised by low serum concentrations of total and free-triiodothyronine (FT3
Search for other papers by Clotilde Saïe in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Samir Saheb in
Google Scholar
PubMed
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Search for other papers by Denis Lemesle in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed
Search for other papers by Christophe Tresallet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
thyrotoxicosis). In the patients with GD, the median TSH receptor antibody level was 16 U/L (range 9–41 U/L). All patients with AIT had type 2 AIT, confirmed by 123 -iodine thyroid scintigraphy (online suppl. Fig.; www.karger.com/doi/10.1159/000507019) or
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Marenza Leo in
Google Scholar
PubMed
Search for other papers by Maria Antonietta Altea in
Google Scholar
PubMed
), MDA, and tert-butyl hydroperoxide-initiated chemiluminescence. The levels of lipid peroxidation products correlate with serum concentration of thyroid hormones in patients with symptomatic hyperthyroidism, but significantly higher values have also been
Search for other papers by Estefanía Rinaldini in
Google Scholar
PubMed
Search for other papers by Fiorella Campo Verde Arboccó in
Google Scholar
PubMed
Search for other papers by Marcelo Ezquer in
Google Scholar
PubMed
Facultad de Ciencias Médicas, Instituto de Fisiología, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by Carlos Gamarra-Luques in
Google Scholar
PubMed
Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by María Belén Hapon in
Google Scholar
PubMed
control levels. All groups had lower T3 levels than controls on L14. At the end of lactation, only T3 remained at control levels in the GC-1 group. Fig. 1. TSH and T3 serum concentrations in rats during gestation and lactation treated with
Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea
Search for other papers by Chae Won Chung in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Kyungsik Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Sue K Park in
Google Scholar
PubMed
Search for other papers by Dal Lae Ju in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Choong Ho Shin in
Google Scholar
PubMed
Search for other papers by Jong Kwan Jun in
Google Scholar
PubMed
Search for other papers by June-Key Chung in
Google Scholar
PubMed
Search for other papers by Yoon Ju Song in
Google Scholar
PubMed
Search for other papers by Young Ah Lee in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Gi Jeong Cheon in
Google Scholar
PubMed
Search for other papers by Sun Wook Cho in
Google Scholar
PubMed
concentrations, participants were divided into three groups: deficient, < 70 μg/L; suboptimal, 70–99 μg/L; and optimal, ≥ 100 μg/L. The range of the deficient group was defined by previous studies ( 17 , 18 , 19 ), and the optimal level was set to the